APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cardiac Marker

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cardiac Marker Industry Growth and Trends Forecast to 2032

Report ID 173975080120 December 2025102 pages

Choose your research edition.

Industry ResearchCardiac Marker Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiac Marker Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cardiac Marker Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiac Marker Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiac Marker Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cardiac Marker market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cardiac Marker is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cardiac Marker is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cardiac Marker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cardiac Marker include BG Medicine, Biomerieux, Critical Diagnostics, DiaDexus, HyTest, Lee BioSolutions, Response Biomedical, Roche Diagnostics and Siemens Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cardiac Marker market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cardiac Marker market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cardiac Marker market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cardiac Marker.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cardiac Marker market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cardiac Marker Market by Company

BG Medicine

Biomerieux

Critical Diagnostics

DiaDexus

HyTest

Lee BioSolutions

Response Biomedical

Roche Diagnostics

Siemens Healthcare

Singulex

Sunfory

Thermo Scientific

Trinity Biotech

Abbott

Cardiac Marker Segment by Type

BNP & NT-proBNP

Troponin (cTnI and cTnT)

Myogloblin

Creatine kinase (CK) MB

Others (hs-CRP, D-Dimer, etc.)

Cardiac Marker Segment by Application

Myocardial Infarction

Acute Coronary Syndrome

Atherosclerosis

Congestive Heart Failure

Others

Cardiac Marker Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiac Marker market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiac Marker and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiac Marker.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cardiac Marker manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cardiac Marker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of BNP & NT-proBNP Table 2. Major Company of Troponin (cTnI and cTnT) Table 3. Major Company of Myogloblin Table 4. Major Company of Creatine kinase (CK) MB Table 5. Major Company of Others (hs-CRP, D-Dimer, etc.) Table 6. Global Cardiac Marker Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Cardiac Marker Sales by Type (2021-2026) & (K Units) Table 8. Global Cardiac Marker Sales Market Share in Volume by Type (2021-2026) Table 9. Global Cardiac Marker Sales by Type (2021-2026) & (US$ Million) Table 10. Global Cardiac Marker Sales Market Share in Value by Type (2021-2026) Table 11. Global Cardiac Marker Price by Type (2021-2026) & (US$/Unit) Table 12. Global Cardiac Marker Sales by Type (2027-2032) & (K Units) Table 13. Global Cardiac Marker Sales Market Share in Volume by Type (2027-2032) Table 14. Global Cardiac Marker Sales by Type (2027-2032) & (US$ Million) Table 15. Global Cardiac Marker Sales Market Share in Value by Type (2027-2032) Table 16. Global Cardiac Marker Price by Type (2027-2032) & (US$/Unit) Table 17. North America Cardiac Marker Sales by Type (2021-2026) & (K Units) Table 18. North America Cardiac Marker Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Cardiac Marker Sales by Type (2021-2026) & (K Units) Table 20. Europe Cardiac Marker Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Cardiac Marker Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Cardiac Marker Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Cardiac Marker Sales by Type (2021-2026) & (K Units) Table 24. Latin America Cardiac Marker Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Cardiac Marker Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Cardiac Marker Sales by Type (2021-2026) & (US$ Million) Table 27. Cardiac Marker Industry Trends Table 28. Cardiac Marker Industry Drivers Table 29. Cardiac Marker Industry Opportunities and Challenges Table 30. Cardiac Marker Industry Restraints Table 31. Global Cardiac Marker Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Cardiac Marker Revenue Market Share by Company (2021-2026) Table 33. Global Cardiac Marker Sales by Company (2021-2026) & (K Units) Table 34. Global Cardiac Marker Sales Share by Company (2021-2026) Table 35. Global Cardiac Marker Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Cardiac Marker Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Cardiac Marker Major Company Production Sites and Headquarters Table 38. Global Cardiac Marker Company, Product Type & Application Table 39. Global Cardiac Marker Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Cardiac Marker by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Cardiac Marker Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Cardiac Marker Sales by Region (2021-2026) & (K Units) Table 44. Global Cardiac Marker Sales Market Share in Volume by Region (2021-2026) Table 45. Global Cardiac Marker Sales by Region (2021-2026) & (US$ Million) Table 46. Global Cardiac Marker Sales Market Share in Value by Region (2021-2026) Table 47. Global Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Cardiac Marker Sales by Region (2027-2032) & (K Units) Table 49. Global Cardiac Marker Sales Market Share in Volume by Region (2027-2032) Table 50. Global Cardiac Marker Sales by Region (2027-2032) & (US$ Million) Table 51. Global Cardiac Marker Sales Market Share in Value by Region (2027-2032) Table 52. Global Cardiac Marker Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Cardiac Marker Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Cardiac Marker Sales by Application (2021-2026) & (K Units) Table 55. Global Cardiac Marker Sales Market Share in Volume by Application (2021-2026) Table 56. Global Cardiac Marker Sales by Application (2021-2026) & (US$ Million) Table 57. Global Cardiac Marker Sales Market Share in Value by Application (2021-2026) Table 58. Global Cardiac Marker Price by Application (2021-2026) & (US$/Unit) Table 59. Global Cardiac Marker Sales by Application (2027-2032) & (K Units) Table 60. Global Cardiac Marker Sales Market Share in Volume by Application (2027-2032) Table 61. Global Cardiac Marker Sales by Application (2027-2032) & (US$ Million) Table 62. Global Cardiac Marker Sales Market Share in Value by Application (2027-2032) Table 63. Global Cardiac Marker Price by Application (2027-2032) & (US$/Unit) Table 64. North America Cardiac Marker Sales by Application (2021-2026) & (K Units) Table 65. North America Cardiac Marker Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Cardiac Marker Sales by Application (2021-2026) & (K Units) Table 67. Europe Cardiac Marker Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Cardiac Marker Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Cardiac Marker Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Cardiac Marker Sales by Application (2021-2026) & (K Units) Table 71. Latin America Cardiac Marker Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Cardiac Marker Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Cardiac Marker Sales by Application (2021-2026) & (US$ Million) Table 74. BG Medicine Company Information Table 75. BG Medicine Business Overview Table 76. BG Medicine Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. BG Medicine Cardiac Marker Product Portfolio Table 78. BG Medicine Recent Development Table 79. Biomerieux Company Information Table 80. Biomerieux Business Overview Table 81. Biomerieux Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Biomerieux Cardiac Marker Product Portfolio Table 83. Biomerieux Recent Development Table 84. Critical Diagnostics Company Information Table 85. Critical Diagnostics Business Overview Table 86. Critical Diagnostics Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Critical Diagnostics Cardiac Marker Product Portfolio Table 88. Critical Diagnostics Recent Development Table 89. DiaDexus Company Information Table 90. DiaDexus Business Overview Table 91. DiaDexus Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. DiaDexus Cardiac Marker Product Portfolio Table 93. DiaDexus Recent Development Table 94. HyTest Company Information Table 95. HyTest Business Overview Table 96. HyTest Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. HyTest Cardiac Marker Product Portfolio Table 98. HyTest Recent Development Table 99. Lee BioSolutions Company Information Table 100. Lee BioSolutions Business Overview Table 101. Lee BioSolutions Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Lee BioSolutions Cardiac Marker Product Portfolio Table 103. Lee BioSolutions Recent Development Table 104. Response Biomedical Company Information Table 105. Response Biomedical Business Overview Table 106. Response Biomedical Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Response Biomedical Cardiac Marker Product Portfolio Table 108. Response Biomedical Recent Development Table 109. Roche Diagnostics Company Information Table 110. Roche Diagnostics Business Overview Table 111. Roche Diagnostics Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Roche Diagnostics Cardiac Marker Product Portfolio Table 113. Roche Diagnostics Recent Development Table 114. Siemens Healthcare Company Information Table 115. Siemens Healthcare Business Overview Table 116. Siemens Healthcare Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Siemens Healthcare Cardiac Marker Product Portfolio Table 118. Siemens Healthcare Recent Development Table 119. Singulex Company Information Table 120. Singulex Business Overview Table 121. Singulex Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Singulex Cardiac Marker Product Portfolio Table 123. Singulex Recent Development Table 124. Sunfory Company Information Table 125. Sunfory Business Overview Table 126. Sunfory Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Sunfory Cardiac Marker Product Portfolio Table 128. Sunfory Recent Development Table 129. Thermo Scientific Company Information Table 130. Thermo Scientific Business Overview Table 131. Thermo Scientific Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Thermo Scientific Cardiac Marker Product Portfolio Table 133. Thermo Scientific Recent Development Table 134. Trinity Biotech Company Information Table 135. Trinity Biotech Business Overview Table 136. Trinity Biotech Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Trinity Biotech Cardiac Marker Product Portfolio Table 138. Trinity Biotech Recent Development Table 139. Abbott Company Information Table 140. Abbott Business Overview Table 141. Abbott Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Abbott Cardiac Marker Product Portfolio Table 143. Abbott Recent Development Table 144. North America Cardiac Marker Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. North America Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 146. North America Cardiac Marker Sales Market Share by Country (2021-2026) Table 147. North America Cardiac Marker Sales Forecast by Country (2027-2032) & (K Units) Table 148. North America Cardiac Marker Sales Market Share Forecast by Country (2027-2032) Table 149. North America Cardiac Marker Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. North America Cardiac Marker Market Size by Country (2021-2026) & (US$ Million) Table 151. North America Cardiac Marker Market Share by Country (2021-2026) Table 152. North America Cardiac Marker Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. North America Cardiac Marker Market Share Forecast by Country (2027-2032) Table 154. Europe Cardiac Marker Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Europe Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 156. Europe Cardiac Marker Sales Market Share by Country (2021-2026) Table 157. Europe Cardiac Marker Sales Forecast by Country (2027-2032) & (K Units) Table 158. Europe Cardiac Marker Sales Market Share Forecast by Country (2027-2032) Table 159. Europe Cardiac Marker Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Europe Cardiac Marker Market Size by Country (2021-2026) & (US$ Million) Table 161. Europe Cardiac Marker Market Share by Country (2021-2026) Table 162. Europe Cardiac Marker Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Europe Cardiac Marker Market Share Forecast by Country (2027-2032) Table 164. Asia-Pacific Cardiac Marker Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. Asia-Pacific Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 166. Asia-Pacific Cardiac Marker Sales Market Share by Country (2021-2026) Table 167. Asia-Pacific Cardiac Marker Sales Forecast by Country (2027-2032) & (K Units) Table 168. Asia-Pacific Cardiac Marker Sales Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific Cardiac Marker Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific Cardiac Marker Market Size by Country (2021-2026) & (US$ Million) Table 171. Asia-Pacific Cardiac Marker Market Share by Country (2021-2026) Table 172. Asia-Pacific Cardiac Marker Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Asia-Pacific Cardiac Marker Market Share Forecast by Country (2027-2032) Table 174. Latin America Cardiac Marker Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 175. Latin America Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 176. Latin America Cardiac Marker Sales Market Share by Country (2021-2026) Table 177. Latin America Cardiac Marker Sales Forecast by Country (2027-2032) & (K Units) Table 178. Latin America Cardiac Marker Sales Market Share Forecast by Country (2027-2032) Table 179. Latin America Cardiac Marker Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Latin America Cardiac Marker Market Size by Country (2021-2026) & (US$ Million) Table 181. Latin America Cardiac Marker Market Share by Country (2021-2026) Table 182. Latin America Cardiac Marker Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Latin America Cardiac Marker Market Share Forecast by Country (2027-2032) Table 184. Middle East and Africa Cardiac Marker Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 185. Middle East and Africa Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 186. Middle East and Africa Cardiac Marker Sales Market Share by Country (2021-2026) Table 187. Middle East and Africa Cardiac Marker Sales Forecast by Country (2027-2032) & (K Units) Table 188. Middle East and Africa Cardiac Marker Sales Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa Cardiac Marker Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa Cardiac Marker Market Size by Country (2021-2026) & (US$ Million) Table 191. Middle East and Africa Cardiac Marker Market Share by Country (2021-2026) Table 192. Middle East and Africa Cardiac Marker Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Middle East and Africa Cardiac Marker Market Share Forecast by Country (2027-2032) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Cardiac Marker Distributors List Table 197. Cardiac Marker Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Cardiac Marker Image Figure 2. Global Cardiac Marker Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiac Marker Market Size (2021-2032) & (US$ Million) Figure 4. Global Cardiac Marker Sales (2021-2032) & (K Units) Figure 5. BNP & NT-proBNP Image Figure 6. Global BNP & NT-proBNP Sales YoY Growth (2021-2032) & (K Units) Figure 7. Troponin (cTnI and cTnT) Image Figure 8. Global Troponin (cTnI and cTnT) Sales YoY Growth (2021-2032) & (K Units) Figure 9. Myogloblin Image Figure 10. Global Myogloblin Sales YoY Growth (2021-2032) & (K Units) Figure 11. Creatine kinase (CK) MB Image Figure 12. Global Creatine kinase (CK) MB Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others (hs-CRP, D-Dimer, etc.) Image Figure 14. Global Others (hs-CRP, D-Dimer, etc.) Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Cardiac Marker Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Cardiac Marker Market Share by Type 2025 VS 2032 Figure 17. North America Cardiac Marker Sales Market Share in Volume by Type in 2025 Figure 18. North America Cardiac Marker Sales Market Share in Value by Type in 2025 Figure 19. Europe Cardiac Marker Sales Market Share in Volume by Type in 2025 Figure 20. Europe Cardiac Marker Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Cardiac Marker Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Cardiac Marker Sales Market Share in Value by Type in 2025 Figure 23. Latin America Cardiac Marker Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Cardiac Marker Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Cardiac Marker Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Cardiac Marker Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Cardiac Marker Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Myocardial Infarction Image Figure 30. Global Myocardial Infarction Sales YoY Growth (2021-2032) & (K Units) Figure 31. Acute Coronary Syndrome Image Figure 32. Global Acute Coronary Syndrome Sales YoY Growth (2021-2032) & (K Units) Figure 33. Atherosclerosis Image Figure 34. Global Atherosclerosis Sales YoY Growth (2021-2032) & (K Units) Figure 35. Congestive Heart Failure Image Figure 36. Global Congestive Heart Failure Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Cardiac Marker Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Cardiac Marker Market Share by Application 2025 VS 2032 Figure 41. North America Cardiac Marker Sales Market Share in Volume by Application in 2025 Figure 42. North America Cardiac Marker Sales Market Share in Value by Application in 2025 Figure 43. Europe Cardiac Marker Sales Market Share in Volume by Application in 2025 Figure 44. Europe Cardiac Marker Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Cardiac Marker Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Cardiac Marker Sales Market Share in Value by Application in 2025 Figure 47. Latin America Cardiac Marker Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Cardiac Marker Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Cardiac Marker Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Cardiac Marker Sales Market Share in Value by Application in 2025 Figure 51. North America Cardiac Marker Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Cardiac Marker Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Cardiac Marker Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Cardiac Marker Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Cardiac Marker Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Cardiac Marker Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Cardiac Marker Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Cardiac Marker Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Cardiac Marker Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Cardiac Marker Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Cardiac Marker Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Cardiac Marker Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Cardiac Marker Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Cardiac Marker Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Cardiac Marker Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Cardiac Marker Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Cardiac Marker Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Cardiac Marker Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Cardiac Marker Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Cardiac Marker Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Cardiac Marker Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Cardiac Marker Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • BNP & NT-proBNP
  • Troponin (cTnI and cTnT)
  • Myogloblin
  • Creatine kinase (CK) MB
  • Others (hs-CRP, D-Dimer, etc.)
Applications
  • Myocardial Infarction
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Congestive Heart Failure
  • Others
Companies covered
  • BG Medicine
  • Biomerieux
  • Critical Diagnostics
  • DiaDexus
  • HyTest
  • Lee BioSolutions
  • Response Biomedical
  • Roche Diagnostics
  • Siemens Healthcare
  • Singulex
  • Sunfory
  • Thermo Scientific
  • Trinity Biotech
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cardiac Marker Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cardiac Marker Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cardiac Marker Market by Type
  6. 1.3.1 BNP & NT-proBNP
  7. 1.3.2 Troponin (cTnI and cTnT)
  8. 1.3.3 Myogloblin
  9. 1.3.4 Creatine kinase (CK) MB
  10. 1.3.5 Others (hs-CRP, D-Dimer, etc.)
  11. 1.4 Global Cardiac Marker Market Size by Type
  12. 1.4.1 Global Cardiac Marker Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Cardiac Marker Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Cardiac Marker Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Cardiac Marker Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Cardiac Marker Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Cardiac Marker Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Cardiac Marker Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Cardiac Marker Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cardiac Marker Industry Trends
  2. 2.2 Cardiac Marker Industry Drivers
  3. 2.3 Cardiac Marker Industry Opportunities and Challenges
  4. 2.4 Cardiac Marker Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cardiac Marker Revenue (2021-2026)
  2. 3.2 Global Top Players by Cardiac Marker Sales (2021-2026)
  3. 3.3 Global Top Players by Cardiac Marker Price (2021-2026)
  4. 3.4 Global Cardiac Marker Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cardiac Marker Major Company Production Sites & Headquarters
  6. 3.6 Global Cardiac Marker Company, Product Type & Application
  7. 3.7 Global Cardiac Marker Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cardiac Marker Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cardiac Marker Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cardiac Marker Tier 1, Tier 2, and Tier 3
4 Cardiac Marker Regional Status and Outlook
  1. 4.1 Global Cardiac Marker Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cardiac Marker Historic Market Size by Region
  3. 4.2.1 Global Cardiac Marker Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cardiac Marker Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cardiac Marker Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cardiac Marker Forecasted Market Size by Region
  7. 4.3.1 Global Cardiac Marker Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cardiac Marker Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cardiac Marker Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cardiac Marker by Application
  1. 5.1 Cardiac Marker Market by Application
  2. 5.1.1 Myocardial Infarction
  3. 5.1.2 Acute Coronary Syndrome
  4. 5.1.3 Atherosclerosis
  5. 5.1.4 Congestive Heart Failure
  6. 5.1.5 Others
  7. 5.2 Global Cardiac Marker Market Size by Application
  8. 5.2.1 Global Cardiac Marker Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Cardiac Marker Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Cardiac Marker Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Cardiac Marker Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Cardiac Marker Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Cardiac Marker Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Cardiac Marker Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Cardiac Marker Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BG Medicine
  2. 6.1.1 BG Medicine Company Information
  3. 6.1.2 BG Medicine Business Overview
  4. 6.1.3 BG Medicine Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BG Medicine Cardiac Marker Product Portfolio
  6. 6.1.5 BG Medicine Recent Developments
  7. 6.2 Biomerieux
  8. 6.2.1 Biomerieux Company Information
  9. 6.2.2 Biomerieux Business Overview
  10. 6.2.3 Biomerieux Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biomerieux Cardiac Marker Product Portfolio
  12. 6.2.5 Biomerieux Recent Developments
  13. 6.3 Critical Diagnostics
  14. 6.3.1 Critical Diagnostics Company Information
  15. 6.3.2 Critical Diagnostics Business Overview
  16. 6.3.3 Critical Diagnostics Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Critical Diagnostics Cardiac Marker Product Portfolio
  18. 6.3.5 Critical Diagnostics Recent Developments
  19. 6.4 DiaDexus
  20. 6.4.1 DiaDexus Company Information
  21. 6.4.2 DiaDexus Business Overview
  22. 6.4.3 DiaDexus Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 DiaDexus Cardiac Marker Product Portfolio
  24. 6.4.5 DiaDexus Recent Developments
  25. 6.5 HyTest
  26. 6.5.1 HyTest Company Information
  27. 6.5.2 HyTest Business Overview
  28. 6.5.3 HyTest Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 HyTest Cardiac Marker Product Portfolio
  30. 6.5.5 HyTest Recent Developments
  31. 6.6 Lee BioSolutions
  32. 6.6.1 Lee BioSolutions Company Information
  33. 6.6.2 Lee BioSolutions Business Overview
  34. 6.6.3 Lee BioSolutions Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lee BioSolutions Cardiac Marker Product Portfolio
  36. 6.6.5 Lee BioSolutions Recent Developments
  37. 6.7 Response Biomedical
  38. 6.7.1 Response Biomedical Company Information
  39. 6.7.2 Response Biomedical Business Overview
  40. 6.7.3 Response Biomedical Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Response Biomedical Cardiac Marker Product Portfolio
  42. 6.7.5 Response Biomedical Recent Developments
  43. 6.8 Roche Diagnostics
  44. 6.8.1 Roche Diagnostics Company Information
  45. 6.8.2 Roche Diagnostics Business Overview
  46. 6.8.3 Roche Diagnostics Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Roche Diagnostics Cardiac Marker Product Portfolio
  48. 6.8.5 Roche Diagnostics Recent Developments
  49. 6.9 Siemens Healthcare
  50. 6.9.1 Siemens Healthcare Company Information
  51. 6.9.2 Siemens Healthcare Business Overview
  52. 6.9.3 Siemens Healthcare Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Siemens Healthcare Cardiac Marker Product Portfolio
  54. 6.9.5 Siemens Healthcare Recent Developments
  55. 6.10 Singulex
  56. 6.10.1 Singulex Company Information
  57. 6.10.2 Singulex Business Overview
  58. 6.10.3 Singulex Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Singulex Cardiac Marker Product Portfolio
  60. 6.10.5 Singulex Recent Developments
  61. 6.11 Sunfory
  62. 6.11.1 Sunfory Company Information
  63. 6.11.2 Sunfory Business Overview
  64. 6.11.3 Sunfory Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sunfory Cardiac Marker Product Portfolio
  66. 6.11.5 Sunfory Recent Developments
  67. 6.12 Thermo Scientific
  68. 6.12.1 Thermo Scientific Company Information
  69. 6.12.2 Thermo Scientific Business Overview
  70. 6.12.3 Thermo Scientific Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Thermo Scientific Cardiac Marker Product Portfolio
  72. 6.12.5 Thermo Scientific Recent Developments
  73. 6.13 Trinity Biotech
  74. 6.13.1 Trinity Biotech Company Information
  75. 6.13.2 Trinity Biotech Business Overview
  76. 6.13.3 Trinity Biotech Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Trinity Biotech Cardiac Marker Product Portfolio
  78. 6.13.5 Trinity Biotech Recent Developments
  79. 6.14 Abbott
  80. 6.14.1 Abbott Company Information
  81. 6.14.2 Abbott Business Overview
  82. 6.14.3 Abbott Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Abbott Cardiac Marker Product Portfolio
  84. 6.14.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Cardiac Marker Sales by Country
  2. 7.1.1 North America Cardiac Marker Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cardiac Marker Sales by Country (2021-2026)
  4. 7.1.3 North America Cardiac Marker Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cardiac Marker Market Size by Country
  6. 7.2.1 North America Cardiac Marker Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cardiac Marker Market Size by Country (2021-2026)
  8. 7.2.3 North America Cardiac Marker Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cardiac Marker Sales by Country
  2. 8.1.1 Europe Cardiac Marker Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cardiac Marker Sales by Country (2021-2026)
  4. 8.1.3 Europe Cardiac Marker Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cardiac Marker Market Size by Country
  6. 8.2.1 Europe Cardiac Marker Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cardiac Marker Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cardiac Marker Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cardiac Marker Sales by Country
  2. 9.1.1 Asia-Pacific Cardiac Marker Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cardiac Marker Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cardiac Marker Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cardiac Marker Market Size by Country
  6. 9.2.1 Asia-Pacific Cardiac Marker Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cardiac Marker Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cardiac Marker Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cardiac Marker Sales by Country
  2. 10.1.1 South America Cardiac Marker Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cardiac Marker Sales by Country (2021-2026)
  4. 10.1.3 South America Cardiac Marker Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cardiac Marker Market Size by Country
  6. 10.2.1 South America Cardiac Marker Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cardiac Marker Market Size by Country (2021-2026)
  8. 10.2.3 South America Cardiac Marker Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cardiac Marker Sales by Country
  2. 11.1.1 Middle East and Africa Cardiac Marker Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cardiac Marker Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cardiac Marker Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cardiac Marker Market Size by Country
  6. 11.2.1 Middle East and Africa Cardiac Marker Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cardiac Marker Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cardiac Marker Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cardiac Marker Value Chain Analysis
  2. 12.1.1 Cardiac Marker Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cardiac Marker Production Mode & Process
  7. 12.2 Cardiac Marker Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cardiac Marker Distributors
  10. 12.2.3 Cardiac Marker Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst